LC-MS/MS determination and pharmacokinetic study of lacidipine in human plasma

ABSTRACT A robust, specific and fully validated LC‐MS/MS method as per general practices of industry has been developed for estimation of lacidipine (LAC) with 100 μL of human plasma using lacidipine‐13C8 as an internal standard (IS). The API‐4000 LC‐MS/MS was operated under the multiple reaction‐mo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biomedical chromatography 2013-07, Vol.27 (7), p.838-845
Hauptverfasser: Chatki, Pankaj Kisan, Hotha, Kishore Kumar, Kolagatla, Pandu Ranga Reddy, Bharathi, D. Vijaya, Venkateswarulu, V.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 845
container_issue 7
container_start_page 838
container_title Biomedical chromatography
container_volume 27
creator Chatki, Pankaj Kisan
Hotha, Kishore Kumar
Kolagatla, Pandu Ranga Reddy
Bharathi, D. Vijaya
Venkateswarulu, V.
description ABSTRACT A robust, specific and fully validated LC‐MS/MS method as per general practices of industry has been developed for estimation of lacidipine (LAC) with 100 μL of human plasma using lacidipine‐13C8 as an internal standard (IS). The API‐4000 LC‐MS/MS was operated under the multiple reaction‐monitoring mode. A simple liquid–liquid extraction process was used to extract LAC and IS from human plasma. The total run time was 3.0 min and the elution of LAC and IS occurred at 1.96 and 1.97 min; this was achieved with a mobile phase consisting of 5 mm ammonium acetate buffer–acetontrile (15:85 v/v) at a flow rate of 0.60 mL/min on a Zorbax SB C18 (50 × 4.6 mm, 5 µm) column. A linear response function was established for the range of concentrations 50–15,000 pg/mL (r > 0.998) for LAC. The current developed method has negligible matrix effect and is free from unwanted adducts and clusters which are formed owing to system such as solvent or mobile phase. The developed assay method was applied to an oral pharmacokinetic study in humans and successfully characterized the pharmacokinetic data up to 72 h. Copyright © 2013 John Wiley & Sons, Ltd.
doi_str_mv 10.1002/bmc.2868
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1366820217</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1366820217</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3598-8930cbd25cc6c31c2267c88c916f7cef424c28f80a21936eed76b9da787dfe4e3</originalsourceid><addsrcrecordid>eNp10EtLAzEUhuEgiq0X8BdIlm6mzWWay1JHbYVW0VYKbkKaZGjs3JzMoP33jlh15erA4eFbvACcYTTACJHhKjcDIpjYA32MpIyQQHgf9BFhMqKCyx44CuEVISQZ4YegR2jMEIplH9xPk2g2H87m0LrG1bkvdOPLAurCwmqt61ybcuML13gDQ9PaLSxTmGnjra-6N_QFXLe5LmCV6ZDrE3CQ6iy40909Bs-3N4tkEk0fxnfJ5TQydCRFJCRFZmXJyBhmKDaEMG6EMBKzlBuXxiQ2RKQCaYIlZc5ZzlbSai64TV3s6DG4-N6t6vKtdaFRuQ_GZZkuXNkGhSljgiCC-R81dRlC7VJV1T7X9VZhpL7qqa6e-qrX0fPdarvKnf2FP7k6EH2Dd5-57b9D6mqW7AZ33ofGffx6XW8U45SP1PJ-rEYvk8frRbJUT_QTEp-Hew</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1366820217</pqid></control><display><type>article</type><title>LC-MS/MS determination and pharmacokinetic study of lacidipine in human plasma</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Chatki, Pankaj Kisan ; Hotha, Kishore Kumar ; Kolagatla, Pandu Ranga Reddy ; Bharathi, D. Vijaya ; Venkateswarulu, V.</creator><creatorcontrib>Chatki, Pankaj Kisan ; Hotha, Kishore Kumar ; Kolagatla, Pandu Ranga Reddy ; Bharathi, D. Vijaya ; Venkateswarulu, V.</creatorcontrib><description>ABSTRACT A robust, specific and fully validated LC‐MS/MS method as per general practices of industry has been developed for estimation of lacidipine (LAC) with 100 μL of human plasma using lacidipine‐13C8 as an internal standard (IS). The API‐4000 LC‐MS/MS was operated under the multiple reaction‐monitoring mode. A simple liquid–liquid extraction process was used to extract LAC and IS from human plasma. The total run time was 3.0 min and the elution of LAC and IS occurred at 1.96 and 1.97 min; this was achieved with a mobile phase consisting of 5 mm ammonium acetate buffer–acetontrile (15:85 v/v) at a flow rate of 0.60 mL/min on a Zorbax SB C18 (50 × 4.6 mm, 5 µm) column. A linear response function was established for the range of concentrations 50–15,000 pg/mL (r &gt; 0.998) for LAC. The current developed method has negligible matrix effect and is free from unwanted adducts and clusters which are formed owing to system such as solvent or mobile phase. The developed assay method was applied to an oral pharmacokinetic study in humans and successfully characterized the pharmacokinetic data up to 72 h. Copyright © 2013 John Wiley &amp; Sons, Ltd.</description><identifier>ISSN: 0269-3879</identifier><identifier>EISSN: 1099-0801</identifier><identifier>DOI: 10.1002/bmc.2868</identifier><identifier>PMID: 23460049</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>Adolescent ; Adult ; Chromatography, High Pressure Liquid - methods ; Dihydropyridines - blood ; Dihydropyridines - chemistry ; Dihydropyridines - pharmacokinetics ; Drug Stability ; human plasma ; Humans ; lacidipine ; LC-MS/MS ; Male ; method validation ; Middle Aged ; pharmacokinetics ; Reproducibility of Results ; Spectrometry, Mass, Electrospray Ionization ; Tandem Mass Spectrometry - methods</subject><ispartof>Biomedical chromatography, 2013-07, Vol.27 (7), p.838-845</ispartof><rights>Copyright © 2013 John Wiley &amp; Sons, Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3598-8930cbd25cc6c31c2267c88c916f7cef424c28f80a21936eed76b9da787dfe4e3</citedby><cites>FETCH-LOGICAL-c3598-8930cbd25cc6c31c2267c88c916f7cef424c28f80a21936eed76b9da787dfe4e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fbmc.2868$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fbmc.2868$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23460049$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chatki, Pankaj Kisan</creatorcontrib><creatorcontrib>Hotha, Kishore Kumar</creatorcontrib><creatorcontrib>Kolagatla, Pandu Ranga Reddy</creatorcontrib><creatorcontrib>Bharathi, D. Vijaya</creatorcontrib><creatorcontrib>Venkateswarulu, V.</creatorcontrib><title>LC-MS/MS determination and pharmacokinetic study of lacidipine in human plasma</title><title>Biomedical chromatography</title><addtitle>Biomed. Chromatogr</addtitle><description>ABSTRACT A robust, specific and fully validated LC‐MS/MS method as per general practices of industry has been developed for estimation of lacidipine (LAC) with 100 μL of human plasma using lacidipine‐13C8 as an internal standard (IS). The API‐4000 LC‐MS/MS was operated under the multiple reaction‐monitoring mode. A simple liquid–liquid extraction process was used to extract LAC and IS from human plasma. The total run time was 3.0 min and the elution of LAC and IS occurred at 1.96 and 1.97 min; this was achieved with a mobile phase consisting of 5 mm ammonium acetate buffer–acetontrile (15:85 v/v) at a flow rate of 0.60 mL/min on a Zorbax SB C18 (50 × 4.6 mm, 5 µm) column. A linear response function was established for the range of concentrations 50–15,000 pg/mL (r &gt; 0.998) for LAC. The current developed method has negligible matrix effect and is free from unwanted adducts and clusters which are formed owing to system such as solvent or mobile phase. The developed assay method was applied to an oral pharmacokinetic study in humans and successfully characterized the pharmacokinetic data up to 72 h. Copyright © 2013 John Wiley &amp; Sons, Ltd.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Chromatography, High Pressure Liquid - methods</subject><subject>Dihydropyridines - blood</subject><subject>Dihydropyridines - chemistry</subject><subject>Dihydropyridines - pharmacokinetics</subject><subject>Drug Stability</subject><subject>human plasma</subject><subject>Humans</subject><subject>lacidipine</subject><subject>LC-MS/MS</subject><subject>Male</subject><subject>method validation</subject><subject>Middle Aged</subject><subject>pharmacokinetics</subject><subject>Reproducibility of Results</subject><subject>Spectrometry, Mass, Electrospray Ionization</subject><subject>Tandem Mass Spectrometry - methods</subject><issn>0269-3879</issn><issn>1099-0801</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10EtLAzEUhuEgiq0X8BdIlm6mzWWay1JHbYVW0VYKbkKaZGjs3JzMoP33jlh15erA4eFbvACcYTTACJHhKjcDIpjYA32MpIyQQHgf9BFhMqKCyx44CuEVISQZ4YegR2jMEIplH9xPk2g2H87m0LrG1bkvdOPLAurCwmqt61ybcuML13gDQ9PaLSxTmGnjra-6N_QFXLe5LmCV6ZDrE3CQ6iy40909Bs-3N4tkEk0fxnfJ5TQydCRFJCRFZmXJyBhmKDaEMG6EMBKzlBuXxiQ2RKQCaYIlZc5ZzlbSai64TV3s6DG4-N6t6vKtdaFRuQ_GZZkuXNkGhSljgiCC-R81dRlC7VJV1T7X9VZhpL7qqa6e-qrX0fPdarvKnf2FP7k6EH2Dd5-57b9D6mqW7AZ33ofGffx6XW8U45SP1PJ-rEYvk8frRbJUT_QTEp-Hew</recordid><startdate>201307</startdate><enddate>201307</enddate><creator>Chatki, Pankaj Kisan</creator><creator>Hotha, Kishore Kumar</creator><creator>Kolagatla, Pandu Ranga Reddy</creator><creator>Bharathi, D. Vijaya</creator><creator>Venkateswarulu, V.</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201307</creationdate><title>LC-MS/MS determination and pharmacokinetic study of lacidipine in human plasma</title><author>Chatki, Pankaj Kisan ; Hotha, Kishore Kumar ; Kolagatla, Pandu Ranga Reddy ; Bharathi, D. Vijaya ; Venkateswarulu, V.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3598-8930cbd25cc6c31c2267c88c916f7cef424c28f80a21936eed76b9da787dfe4e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Chromatography, High Pressure Liquid - methods</topic><topic>Dihydropyridines - blood</topic><topic>Dihydropyridines - chemistry</topic><topic>Dihydropyridines - pharmacokinetics</topic><topic>Drug Stability</topic><topic>human plasma</topic><topic>Humans</topic><topic>lacidipine</topic><topic>LC-MS/MS</topic><topic>Male</topic><topic>method validation</topic><topic>Middle Aged</topic><topic>pharmacokinetics</topic><topic>Reproducibility of Results</topic><topic>Spectrometry, Mass, Electrospray Ionization</topic><topic>Tandem Mass Spectrometry - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chatki, Pankaj Kisan</creatorcontrib><creatorcontrib>Hotha, Kishore Kumar</creatorcontrib><creatorcontrib>Kolagatla, Pandu Ranga Reddy</creatorcontrib><creatorcontrib>Bharathi, D. Vijaya</creatorcontrib><creatorcontrib>Venkateswarulu, V.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biomedical chromatography</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chatki, Pankaj Kisan</au><au>Hotha, Kishore Kumar</au><au>Kolagatla, Pandu Ranga Reddy</au><au>Bharathi, D. Vijaya</au><au>Venkateswarulu, V.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>LC-MS/MS determination and pharmacokinetic study of lacidipine in human plasma</atitle><jtitle>Biomedical chromatography</jtitle><addtitle>Biomed. Chromatogr</addtitle><date>2013-07</date><risdate>2013</risdate><volume>27</volume><issue>7</issue><spage>838</spage><epage>845</epage><pages>838-845</pages><issn>0269-3879</issn><eissn>1099-0801</eissn><abstract>ABSTRACT A robust, specific and fully validated LC‐MS/MS method as per general practices of industry has been developed for estimation of lacidipine (LAC) with 100 μL of human plasma using lacidipine‐13C8 as an internal standard (IS). The API‐4000 LC‐MS/MS was operated under the multiple reaction‐monitoring mode. A simple liquid–liquid extraction process was used to extract LAC and IS from human plasma. The total run time was 3.0 min and the elution of LAC and IS occurred at 1.96 and 1.97 min; this was achieved with a mobile phase consisting of 5 mm ammonium acetate buffer–acetontrile (15:85 v/v) at a flow rate of 0.60 mL/min on a Zorbax SB C18 (50 × 4.6 mm, 5 µm) column. A linear response function was established for the range of concentrations 50–15,000 pg/mL (r &gt; 0.998) for LAC. The current developed method has negligible matrix effect and is free from unwanted adducts and clusters which are formed owing to system such as solvent or mobile phase. The developed assay method was applied to an oral pharmacokinetic study in humans and successfully characterized the pharmacokinetic data up to 72 h. Copyright © 2013 John Wiley &amp; Sons, Ltd.</abstract><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>23460049</pmid><doi>10.1002/bmc.2868</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0269-3879
ispartof Biomedical chromatography, 2013-07, Vol.27 (7), p.838-845
issn 0269-3879
1099-0801
language eng
recordid cdi_proquest_miscellaneous_1366820217
source MEDLINE; Access via Wiley Online Library
subjects Adolescent
Adult
Chromatography, High Pressure Liquid - methods
Dihydropyridines - blood
Dihydropyridines - chemistry
Dihydropyridines - pharmacokinetics
Drug Stability
human plasma
Humans
lacidipine
LC-MS/MS
Male
method validation
Middle Aged
pharmacokinetics
Reproducibility of Results
Spectrometry, Mass, Electrospray Ionization
Tandem Mass Spectrometry - methods
title LC-MS/MS determination and pharmacokinetic study of lacidipine in human plasma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T21%3A47%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=LC-MS/MS%20determination%20and%20pharmacokinetic%20study%20of%20lacidipine%20in%20human%20plasma&rft.jtitle=Biomedical%20chromatography&rft.au=Chatki,%20Pankaj%20Kisan&rft.date=2013-07&rft.volume=27&rft.issue=7&rft.spage=838&rft.epage=845&rft.pages=838-845&rft.issn=0269-3879&rft.eissn=1099-0801&rft_id=info:doi/10.1002/bmc.2868&rft_dat=%3Cproquest_cross%3E1366820217%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1366820217&rft_id=info:pmid/23460049&rfr_iscdi=true